Response of alpha-fetoprotein to chemotherapy in patients with hepatomas.
D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000276:immunology*; D002865:Chromomycins / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005326:Fetal Proteins / Q000032:analysis*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D008113:Liver Neoplasms / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use
D000510:Alpha-Globulins; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002865:Chromomycins; D005326:Fetal Proteins; D008937:Mitomycins; D003520:Cyclophosphamide; D005472:Fluorouracil